GENTAUR EUROPE  +32 1658 9045 +32 1650 9045BELGIUM1 tel +32 2 732 5688 fax +32 2 732 4414 [email protected] Av. de l' Armée 68 B-1040 Brussels France tel 01 43 25 01 50 fax 01 43 25 01 60 9, rue Lagrange 75005 Paris Italy tel 02 36 00 65 93 fax +32 16 50 90 45 20135 Milano Germany tel +32 16 58 90 45 fax +32 16 50 90 45 Forckenbeckstraße 6 D-52074 Aachen Japan tel +81 78 386 0860 fax +81 78 306 0296 Minaatojimaminami-manchi Chuo-ku, Kobe 065-0047  |
Troponin I EIA
Regulatory Status: For In-Vitro Diagnostic Use
Discipline: Hypertension / Cardiac Evaluation
Sample Type: Serum
Size: 96 Wells
Range: 1.5 - 100 ng/ml
Sensitivity: 1.0 ng/ml
Incubation Time: 1 hr and 50 min
- Elisa Troponin I kit
- code: 1215-41
- price :333.5 EUR / kit
Cardiac Troponin I is a protein found incardiac muscle, with a molecular weight of22.500 daltons. Together with Troponin T and C, it forms a structural complex which – aftercardiac damage – is released into blood circulation.
Both free Troponin I and Troponin I in complex are measured. Troponin I is also found in skeletal muscles, but it differs in its amino acid composition from cardiac TroponinI. These two Troponins can be distinguished immunologically.
• Troponin I is released into blood stream soon after onset of acute cardiac damage.Utilising sensitive immunological methods,a detectable level is reached after 3-6 hours after AMI. cTnI concentration in normal serum is below 0.1 ng/ml. Levels as high as 100 -300 ng/ml have been measured with some AMI patients.USE OF THE QUANTITATIVE ELISA KIT
• The ELISA Troponin I test is used to examine human plasma or serum samples to detect elevated cTnI levels.
• Ideal for use in laboratory environments of hospitals and health care centers.
• The assay can be performed in just 75minutes.
• No hook effect.
• Detection time from 3-6 hours up to5-8 days from potential patient AMI.
• Can be used with other diagnostic methods to detect myocardial damage.
• No test-specific training is required.
• Ready-to-use, stable liquid standards.
• Clinical experiments show complete success in indicating cTnI positive samples, also incase of micro infarcts.
